Eucalia - Public Comps and Valuation Multiples

Eucalia Overview

About Eucalia

Eucalia Inc is engaged in total medical management support, Operation of nursing care homes & Total support business for senior life, medical equipment business, etc.

Founded

2005

HQ

Employees

n/a

Website

eucalia.jp

Sectors

EHR & Practice Management

Financials

LTM Revenue $151M

LTM EBITDA $26.6M

EV

$348M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Eucalia Financials

As of September 2025, Eucalia reported last 12-month revenue of $151M and EBITDA of $26.6M.

In the same period, Eucalia generated $66.0M in LTM gross profit and $16.6M in net income.

See Eucalia valuation multiples based on analyst estimates

Eucalia P&L

In the most recent fiscal year, Eucalia reported revenue of $130M and EBITDA of $29.2M.

Eucalia expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Eucalia valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$151M	XXX	$130M	XXX	XXX	XXX
Gross Profit	$66.0M	XXX	$57.0M	XXX	XXX	XXX
Gross Margin	44%	XXX	44%	XXX	XXX	XXX
EBITDA	$26.6M	XXX	$29.2M	XXX	XXX	XXX
EBITDA Margin	18%	XXX	22%	XXX	XXX	XXX
EBIT	$18.2M	XXX	$15.0M	XXX	XXX	XXX
EBIT Margin	12%	XXX	12%	XXX	XXX	XXX
Net Profit	$16.6M	XXX	$13.3M	XXX	XXX	XXX
Net Margin	11%	XXX	10%	XXX	XXX	XXX
Net Debt	XXX	XXX	$59.2M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Eucalia including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $151M. EBITDA for the last twelve months was $26.6M. In the most recent fiscal year, Eucalia achieved $130M in revenue and $29.2M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$151M	Analyst estimates available to subscribers	$130M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$66.0M	Analyst estimates available to subscribers	$57.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	43.8% gross margin	Analyst estimates available to subscribers	43.8% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$26.6M	Analyst estimates available to subscribers	$29.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	17.7% EBITDA margin	Analyst estimates available to subscribers	22.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$18.2M	Analyst estimates available to subscribers	$15.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	12.1% EBIT margin	Analyst estimates available to subscribers	11.6% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$16.6M	Analyst estimates available to subscribers	$13.3M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	11.0% net profit margin	Analyst estimates available to subscribers	10.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$59.2M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Eucalia

This financial data table provides comprehensive performance metrics for Eucalia, a company based in Japan. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Eucalia generated $151M in revenue over the last twelve months.
The company achieved $26.6M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $66.0M.
Net income over the last twelve months reached $16.6M.

Fiscal Year Performance

In the most recent fiscal year, Eucalia reported $130M in total revenue.
Fiscal year EBITDA was $29.2M.
The company maintained a gross profit margin of 43.8% in the most recent fiscal year.
EBITDA margin for the fiscal year was 22.4%.
Net profit margin reached 10.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Eucalia. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Eucalia Stock Performance

Eucalia has current market cap of JPY 33.7B (or $221M), and EV of JPY 53.1B (or $348M).

Market Cap Evolution

Eucalia Stock Data

As of October 17, 2025, Eucalia's stock price is JPY 946 (or $6).

See Eucalia trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$348M	$221M	XXX	XXX	XXX	XXX	$0.48

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Eucalia Valuation Multiples

Eucalia's trades at 2.7x EV/Revenue multiple, and 11.9x EV/EBITDA.

See valuation multiples for Eucalia and 15K+ public comps

Eucalia Financial Valuation Multiples

As of October 17, 2025, Eucalia has market cap of $221M and EV of $348M.

Equity research analysts estimate Eucalia's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Eucalia has a P/E ratio of 13.3x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$221M	XXX	$221M	XXX	XXX	XXX
EV (current)	$348M	XXX	$348M	XXX	XXX	XXX
EV/Revenue	2.3x	XXX	2.7x	XXX	XXX	XXX
EV/EBITDA	13.1x	XXX	11.9x	XXX	XXX	XXX
EV/EBIT	19.2x	XXX	23.2x	XXX	XXX	XXX
EV/Gross Profit	5.3x	XXX	n/a	XXX	XXX	XXX
P/E	13.3x	XXX	16.6x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-1010.0x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Eucalia Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Eucalia Margins & Growth Rates

Eucalia's last 12 month revenue growth is 17%

Eucalia's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Eucalia's rule of 40 is 33% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Eucalia's rule of X is 60% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Eucalia and other 15K+ public comps

Eucalia Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	17%	XXX	18%	XXX	XXX	XXX
EBITDA Margin	18%	XXX	22%	XXX	XXX	XXX
EBITDA Growth	26%	XXX	21%	XXX	XXX	XXX
Rule of 40	33%	XXX	39%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	60%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	32%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial